Cognizant announced its collaboration with Boehringer Ingelheim, a leading research-driven biopharmaceutical company, to accelerate the speed and quality of drug development. medicinal therapies. Leveraging Veeva Development Cloud, Cognizant will help Boehringer Ingelheim unify medicinal development processes and data into a connected technology ecosystem, improving collaboration between clinical, regulatory and quality functions, the statement said. “Achieving…